NO178564C - Framgangsmåte for framstilling av et system for administrering av aktive medikamenter gjennom slimhinner - Google Patents

Framgangsmåte for framstilling av et system for administrering av aktive medikamenter gjennom slimhinner

Info

Publication number
NO178564C
NO178564C NO890283A NO890283A NO178564C NO 178564 C NO178564 C NO 178564C NO 890283 A NO890283 A NO 890283A NO 890283 A NO890283 A NO 890283A NO 178564 C NO178564 C NO 178564C
Authority
NO
Norway
Prior art keywords
mucosa
preparing
active drugs
administering active
administering
Prior art date
Application number
NO890283A
Other languages
English (en)
Norwegian (no)
Other versions
NO890283L (no
NO178564B (no
NO890283D0 (no
Inventor
Lisbeth Illum
Original Assignee
Danbiosyst Uk Ltd
Cosmas Damian Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Danbiosyst Uk Ltd, Cosmas Damian Ltd filed Critical Danbiosyst Uk Ltd
Publication of NO890283L publication Critical patent/NO890283L/no
Publication of NO890283D0 publication Critical patent/NO890283D0/no
Publication of NO178564B publication Critical patent/NO178564B/no
Publication of NO178564C publication Critical patent/NO178564C/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1658—Proteins, e.g. albumin, gelatin

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Otolaryngology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
NO890283A 1987-05-22 1989-01-23 Framgangsmåte for framstilling av et system for administrering av aktive medikamenter gjennom slimhinner NO178564C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB878712176A GB8712176D0 (en) 1987-05-22 1987-05-22 Drug delivery system
PCT/GB1988/000396 WO1988009163A1 (en) 1987-05-22 1988-05-20 Enhanced uptake drug delivery system

Publications (4)

Publication Number Publication Date
NO890283L NO890283L (no) 1989-01-23
NO890283D0 NO890283D0 (no) 1989-01-23
NO178564B NO178564B (no) 1996-01-15
NO178564C true NO178564C (no) 1996-04-24

Family

ID=10617794

Family Applications (1)

Application Number Title Priority Date Filing Date
NO890283A NO178564C (no) 1987-05-22 1989-01-23 Framgangsmåte for framstilling av et system for administrering av aktive medikamenter gjennom slimhinner

Country Status (10)

Country Link
EP (1) EP0391896B1 (sv)
JP (1) JP2914670B2 (sv)
AU (1) AU614290B2 (sv)
CA (1) CA1324079C (sv)
DE (1) DE3888201T2 (sv)
DK (1) DK175316B1 (sv)
FI (1) FI97444C (sv)
GB (2) GB8712176D0 (sv)
NO (1) NO178564C (sv)
WO (1) WO1988009163A1 (sv)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU610083B2 (en) * 1986-08-18 1991-05-16 Clinical Technologies Associates, Inc. Delivery systems for pharmacological agents
US4865850A (en) * 1986-09-08 1989-09-12 See/Shell Biotechnology, Inc. Dietary fat reduction
US6024983A (en) * 1986-10-24 2000-02-15 Southern Research Institute Composition for delivering bioactive agents for immune response and its preparation
US5075109A (en) * 1986-10-24 1991-12-24 Southern Research Institute Method of potentiating an immune response
WO1990011079A1 (en) * 1989-03-29 1990-10-04 Alcon Laboratories, Inc. Use of monoacyl phosphoglycerides to enhance the corneal penetration of ophthalmic drugs
US5298243A (en) * 1988-10-20 1994-03-29 Denki Kagaku Kogyo Kabushiki Kaisha Colony stimulating factor-gelatin conjugate
ES2089011T3 (es) * 1989-02-17 1996-10-01 Liposome Co Inc Excipiente lipidico de administracion nasal y aplicacion topica.
US5554388A (en) * 1989-02-25 1996-09-10 Danbiosyst Uk Limited Systemic drug delivery compositions comprising a polycationi substance
US5725871A (en) * 1989-08-18 1998-03-10 Danbiosyst Uk Limited Drug delivery compositions comprising lysophosphoglycerolipid
GB8918879D0 (en) * 1989-08-18 1989-09-27 Danbiosyst Uk Pharmaceutical compositions
GB2237510B (en) * 1989-11-04 1993-09-15 Danbiosyst Uk Small particle drug compositions for nasal administration
US5707644A (en) * 1989-11-04 1998-01-13 Danbiosyst Uk Limited Small particle compositions for intranasal drug delivery
GB9001635D0 (en) * 1990-01-24 1990-03-21 Ganderton David Aerosol carriers
GB9012663D0 (en) * 1990-06-07 1990-08-01 Erba Carlo Spa Galenic formulations containing cyclodextrins
DK49791D0 (da) * 1991-03-20 1991-03-20 Novo Nordisk As Nasalt pulverpraeparat
IT1247472B (it) * 1991-05-31 1994-12-17 Fidia Spa Processo per la preparazione di microsfere contenenti componenti biologicamente attivi.
EP0566135A1 (en) * 1992-04-17 1993-10-20 Takeda Chemical Industries, Ltd. Transmucosal composition comprising a peptide and a cytidine derivative
EP1013270A3 (en) * 1992-12-02 2001-03-28 Alkermes Controlled Therapeutics, Inc. Controlled release growth hormone containing microspheres
US5549908A (en) * 1993-05-20 1996-08-27 The University Of Akron Hydrolytically labile microspheres of polysaccharide crosslinked with cyanogen halide and their application in wound dressings
US5830853A (en) * 1994-06-23 1998-11-03 Astra Aktiebolag Systemic administration of a therapeutic preparation
IS1796B (is) * 1993-06-24 2001-12-31 Ab Astra Fjölpeptíð lyfjablanda til innöndunar sem einnig inniheldur eykjaefnasamband
TW402506B (en) * 1993-06-24 2000-08-21 Astra Ab Therapeutic preparation for inhalation
US5747445A (en) * 1993-06-24 1998-05-05 Astra Aktiebolag Therapeutic preparation for inhalation
US6632456B1 (en) 1993-06-24 2003-10-14 Astrazeneca Ab Compositions for inhalation
US5506203C1 (en) * 1993-06-24 2001-02-06 Astra Ab Systemic administration of a therapeutic preparation
SE9303574D0 (sv) * 1993-11-01 1993-11-01 Kabi Pharmacia Ab Composition for drug delivery and method the manufacturing thereof
US6165976A (en) * 1994-06-23 2000-12-26 Astra Aktiebolag Therapeutic preparation for inhalation
EP1283035A3 (en) 1994-12-22 2003-03-19 AstraZeneca AB Therapeutic preparation for inhalation containing parathyroid hormone
US6524557B1 (en) 1994-12-22 2003-02-25 Astrazeneca Ab Aerosol formulations of peptides and proteins
GB9522351D0 (en) * 1995-11-01 1996-01-03 Medeva Holdings Bv Vaccine compositions
US5874064A (en) * 1996-05-24 1999-02-23 Massachusetts Institute Of Technology Aerodynamically light particles for pulmonary drug delivery
US5985309A (en) * 1996-05-24 1999-11-16 Massachusetts Institute Of Technology Preparation of particles for inhalation
US6652837B1 (en) 1996-05-24 2003-11-25 Massachusetts Institute Of Technology Preparation of novel particles for inhalation
GB9700624D0 (en) 1997-01-14 1997-03-05 Danbiosyst Uk Drug delivery composition
US6391452B1 (en) 1997-07-18 2002-05-21 Bayer Corporation Compositions for nasal drug delivery, methods of making same, and methods of removing residual solvent from pharmaceutical preparations
US20060165606A1 (en) 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
US6309623B1 (en) 1997-09-29 2001-10-30 Inhale Therapeutic Systems, Inc. Stabilized preparations for use in metered dose inhalers
US6433040B1 (en) 1997-09-29 2002-08-13 Inhale Therapeutic Systems, Inc. Stabilized bioactive preparations and methods of use
US6565885B1 (en) 1997-09-29 2003-05-20 Inhale Therapeutic Systems, Inc. Methods of spray drying pharmaceutical compositions
JP2000290184A (ja) * 1999-04-01 2000-10-17 Kyowa Hakko Kogyo Co Ltd 経鼻投与製剤
AU2001231000A1 (en) * 2000-01-19 2001-07-31 Pharmaceutical Discovery Corporation Dry powder formulations of antihistamine for nasal administration
EP1280520B2 (en) 2000-05-10 2018-03-21 Novartis AG Phospholipid-based powders for drug delivery
US8404217B2 (en) 2000-05-10 2013-03-26 Novartis Ag Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
GB0027357D0 (en) 2000-11-09 2000-12-27 Bradford Particle Design Plc Particle formation methods and their products
WO2003026699A1 (fr) * 2001-09-26 2003-04-03 Tanabe Seiyaku Co., Ltd. Compositions medicinales favorisant l'absorption de medicaments
TWI324518B (en) 2001-12-19 2010-05-11 Nektar Therapeutics Pulmonary delivery of aminoglycosides
US9339459B2 (en) 2003-04-24 2016-05-17 Nektar Therapeutics Particulate materials
NL1022442C2 (nl) * 2003-01-20 2004-07-22 Tno Toepassing van lipide ter verbetring van de opname van nutrienten en (farmaceutisch) actieve stoffen.
US7591999B2 (en) * 2003-03-04 2009-09-22 Mitsubishi Tanabe Pharma Corporation Powdery preparation for nasal administration
JP2007500243A (ja) * 2003-06-09 2007-01-11 ナステック・ファーマシューティカル・カンパニー・インコーポレーテッド 成長ホルモンの増進された経粘膜送達のための組成物および方法
US9808030B2 (en) 2011-02-11 2017-11-07 Grain Processing Corporation Salt composition
CA2936493C (en) 2014-01-27 2022-08-09 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Nanoencapsulation of hydrophilic active compounds

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3681500A (en) * 1969-12-12 1972-08-01 Boehringer Sohn Ingelheim Spray compositions for treatment of obstructive disorders of the respiratory tract and methods therefor
JPS59163313A (ja) * 1983-03-09 1984-09-14 Teijin Ltd 経鼻投与用ペプチドホルモン類組成物
GB8514090D0 (en) * 1985-06-04 1985-07-10 Sandoz Ltd Organic compounds
ES2053549T3 (es) * 1986-08-11 1994-08-01 Innovata Biomed Ltd Un proceso para la preparacion de una formulacion farmaceutica apropiada para inhalacion.

Also Published As

Publication number Publication date
GB8924696D0 (en) 1990-09-05
NO890283L (no) 1989-01-23
GB8712176D0 (en) 1987-06-24
WO1988009163A1 (en) 1988-12-01
DK583789A (da) 1990-01-18
FI97444B (sv) 1996-09-13
DE3888201D1 (de) 1994-04-07
GB2231495A (en) 1990-11-21
DK175316B1 (da) 2004-08-16
DE3888201T2 (de) 1994-07-14
JP2914670B2 (ja) 1999-07-05
AU1793188A (en) 1988-12-21
FI97444C (sv) 1996-12-27
EP0391896A1 (en) 1990-10-17
EP0391896B1 (en) 1994-03-02
AU614290B2 (en) 1991-08-29
NO178564B (no) 1996-01-15
JPH02503915A (ja) 1990-11-15
NO890283D0 (no) 1989-01-23
CA1324079C (en) 1993-11-09
FI895555A0 (sv) 1989-11-21
GB2231495B (en) 1991-08-28
DK583789D0 (da) 1989-11-21

Similar Documents

Publication Publication Date Title
NO178564C (no) Framgangsmåte for framstilling av et system for administrering av aktive medikamenter gjennom slimhinner
NO173726C (no) Fremgangsmaate for fremstilling av et oralt terapeutisk system for administrering av karbamazpin
NO176902C (no) Fremgangsmåte for fremstilling av en doseringsenhet for avgivelse av et aktivt middel
GR3032101T3 (en) Vehicles for oral administration of a specific pharmaceutically active acid labile substance.
NO173486C (no) Fremgangsmaate for fremstilling av et farmasoeytisk preparat for transdermal administrasjon av legemidler
NO175515C (no) Fremgangsmåte for fremstilling av et farmasöytisk preparat for perkutan tilförsel
NO177038C (no) Fremgangsmåte for fremstilling av et farmasöytisk doseringssystem
FI880928A (sv) Förfarande för framställning av en farmaceutisk tablett och ett farmaceutiskt granulat
NO883667L (no) Kapsel for farmasoeytisk virksomme innholdsstoffer av en droge.
FI901787A0 (sv) Förfarande för framställning av en läkemedel avgivande komposition
PT86986A (pt) Substituted 9-amino-tetrahydroacridines and related compounds a process for their preparation and their use as medicaments
DE68900994D1 (de) Diphosphonsaeurederivat enthaltendes arzneimittel zur oralen gabe.
DK528988A (da) Laegemiddelafgivelsessystem
NO883500L (no) Fremgangsmaate for fremstilling av et farmasoeytisk aktivt nitrometan.
NO177485C (no) Fremgangsmåte for fremstilling av et farmasöytisk inhalasjonspreparat
DK79889D0 (da) Flerlagsplaster til transdermal laegemiddeladministration
NO179396C (no) Fremgangsmåte ved fremstilling av en medikamentell administreringsform for drövtyggere
NO178527C (no) Fremgangsmåte for fremstilling av et medikament for oral administrering av fluoridion
NO865028L (no) Fremgangsmaate for fremstilling av et terapeutisk system.
IL87038A0 (en) Substituted benzimidazoles,a process for the preparation thereof and pharmaceutical formulations containing them
IT1223343B (it) Formulazioni farmaceutiche per somministrazione transdermica
PT89296A (pt) Processo para a preparacao de unidades de dosagem contendo produtos farmaceuticos para administracao por via oral
PT87186A (pt) Imidazothiadiazine derivatives a process for preparing the same and their use as medicaments
NO875461D0 (no) Fremgangsmaate for fremstilling av et terapeutisk aktivt peptid.
PT86642A (pt) Arylthiadiazolylsulfonamides and derivatives a process for thir preparation and their use as medicaments